•Glucose intolerance (15%-50%)•Obesity (15%)•Type II diabetes (10%)•Metabolic syndrome•Reduced insulin sensitivity•Gluten-sensitive enteropathy (celiac disease). This evidence concerns the gene INS and metabolic syndrome.